|
HS Code |
671104 |
As an accredited 3-Bromophenylacetone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 3-Bromophenylacetone prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every day in the lab, certain chemicals stand out for their reliable performance and versatility. 3-Bromophenylacetone sits among those compounds chemists reach for, not because it promises novelty, but because it delivers steady results across multiple applications. This organic intermediate, marked by its phenylacetone backbone and bromine on the third carbon, has become a trusted starting point for synthesis, especially in the pharmaceutical and fine chemical sectors. Over years behind the bench, I’ve seen firsthand how subtle changes in molecular structure, like bromination at a specific position, can totally change a compound’s character and broaden what you can do with it.
3-Bromophenylacetone, with the formula C9H9BrO, is more than just a mouthful. Its structure combines a phenyl group linked to an acetone moiety, with a single bromine atom attached to the third spot on the ring. This unique substitution isn’t some arbitrary design. The electron-withdrawing effect from bromine transforms the reactivity of the whole molecule. I’ve seen researchers opt for this compound because that one swap from hydrogen to bromine opens new patterns of reactivity, crucial for synthesizing specific pharmaceuticals or agrochemicals.
Subtle details matter. 4-bromophenylacetone, for example, places the bromine on the fourth carbon, and that shift can mean big changes when building complex molecules. By keeping it on the third carbon, 3-bromophenylacetone offers different pathways for later reactions, especially if you want to do further substitution or couple it to other rings. Through trial and error, many chemists learn that even these small details dictate the success or failure of a synthetic route.
In most labs, 3-bromophenylacetone shows up as a clear to slightly yellow liquid, with a density and viscosity that make it easy to pour in customary glassware. It works well at room temperature, staying stable under normal storage conditions. No one wants to struggle with a chemical that gums up at the slightest drop in temperature, so this reliability matters during hectic runs or quick one-pot syntheses. The boiling point, hovering around the 130–140°C range under reduced pressure, makes it straightforward to distill or purify for custom projects.
My own experience—along with stories gathered in crowded conference halls—keeps bringing up one fact: 3-bromophenylacetone shows up most often in the early stages of complex syntheses. It’s a go-to intermediate for making specific benzylamines, which later become building blocks for pharmaceuticals, dyes, and specialty chemicals. The aryl group, activated by bromine, creates new opportunities for coupling reactions such as Suzuki or Heck reactions, both mainstays in the medicinal chemistry playbook.
Imagine trying to build a novel central nervous system drug requiring a precise aryl-alkyl backbone. 3-Bromophenylacetone sits right at the fork in the road, letting you go several ways: nucleophilic substitution, halogen-lithium exchange, or direct coupling. With its bromine ready to leave, nucleophiles can attack exactly where you need them. Over the years, I’ve watched colleagues cut weeks out of synthesis timelines by cutting down protection-deprotection steps, all because they chose the right functionalized acetone derivative from the start.
Outside textbook chemistry, the day-to-day grind of R&D values a compound that doesn’t complicate things. 3-Bromophenylacetone allows for rapid iterative experimentation. Its chemical behavior is well-studied, which means new hires and senior scientists alike can predict how it will perform under common reaction conditions. There’s little guesswork about reactivity or incompatibility, reducing wasted batches and frustration during long hours at the bench. Teams juggling deadlines don’t want to gamble resources, and this is where a thoroughly characterized compound comes into play.
I've met process chemists at industry roundtables who often cite 3-bromophenylacetone as a linchpin—especially when scaling syntheses from discovery to kilo scale. Because it performs consistently, whether in 10-gram or 10-kilogram batches, it takes guesswork out of the cost and feasibility projections. The less uncertainty in scaling up, the fewer surprises for everyone involved, from chemists to procurement to safety officers.
3-Bromophenylacetone doesn’t always make the obvious choice. In fact, chemists often debate its merits against better-known acetophenones or different halogenated derivatives. Compared to 2-bromophenylacetone or 4-bromophenylacetone, the third position yields a distinct balance between electron density and steric crowding. That balance makes it preferred for certain Friedel–Crafts alkylations and metal-catalyzed cross-couplings. Some will point out that 4-bromophenylacetone does the trick for para-linked frameworks, especially in dye chemistry, but the ortho isomer tends to suffer from side reactions and inconsistent yields.
Among non-brominated phenylacetone analogs, the advantages of 3-bromophenylacetone hinge on its functional versatility. Standard phenylacetone, widely used in organic synthesis, lacks a leaving group like bromine. If you’re making substituted anilines or trying for a quick carbon–carbon bond formation, this lack slows down the entire process and forces extra steps. In my own career, I’ve watched projects become bogged down by these extra layers, only to move forward smoothly once a brominated or otherwise pre-functionalized starting point replaced the old standby.
Chlorinated or iodinated analogs do exist. Iodine gives higher reactivity in certain coupling reactions, but costs spike, and iodine-based compounds are generally less stable. As for chloro-phenylacetones, their lower reactivity means longer reaction times and lower yields. 3-Bromophenylacetone strikes a kind of “Goldilocks zone”—reactive enough to enable clean chemistry, robust enough for storage, and reasonably priced, especially when purchasing at scale.
Nothing kills project momentum faster than running into purity pitfalls. 3-Bromophenylacetone is commercially available at high purity grades, many exceeding 98%. For sensitive pharmaceutical syntheses, lab teams customarily confirm identity and purity using NMR, GC-MS, or HPLC. Consistent purity has meant fewer headaches in regulatory environments, and those handling clinical R&D can rest easier knowing impurities fall within tight thresholds.
Tracking lot-to-lot consistency, as anyone in regulatory compliance knows, forms the backbone of good manufacturing practices. This product’s popularity keeps suppliers on their toes, regularly publishing certificates of analysis—sometimes batch by batch. In the competitive world of custom synthesis, hearing stories about delayed launches due to questionable starting material teaches the importance of sticking with compounds enjoying broad supply chain reliability.
Working with brominated organics always demands respect for safety. My lab experience drilled this into me: improper ventilation or careless handling can turn a routine day sour fast. 3-Bromophenylacetone should be stored tightly closed, away from direct sunlight and incompatible materials, as you would with most volatiles. Gloves, goggles, and lab coats are basic protocol, and fume hoods keep inhalation risks minimal.
Disposal poses challenges too, since brominated waste counts as hazardous. Labs focused on environmental responsibility often partner with specialized disposal services, making sure to neutralize and dispose of any leftover reagent according to local regulations. The growing trend in “green chemistry” only underlines the need for minimization and proper destruction of halogenated waste. Over the years, I’ve noticed institutions growing more proactive about recycling solvents and reducing inventory of high-hazard reagents, and 3-bromophenylacetone fits into that broader culture of risk awareness.
The choice of intermediate defines more than just the outcome of a single reaction; it can influence the time, cost, and safety of projects stretching over months or years. I recall a time—working late with a graduate student—when a poorly chosen intermediate turned what should have been a two-week synthesis into a two-month headache. Using 3-bromophenylacetone as the foundational block, on the other hand, usually meant things went smoother, yields edged higher, and trouble with purification fell away.
It’s easy to underestimate small decisions in early project stages. Yet, selecting a well-characterized reagent with a strong track record can spell the difference between a promising new compound reaching animal trials or falling short due to supply hiccups or regulatory headaches. Academic groups focus on pushing boundaries, but in industry—where time equals money—picking the right intermediate maximizes not just efficiency, but reproducibility and eventual compliance with quality standards.
No chemical solves all problems. 3-Bromophenylacetone displays susceptibility to light-induced degradation and hydrolysis if left exposed for too long. Routine good practice includes storing it in amber bottles, reducing unnecessary opening, and keeping desiccants in cabinets. Smaller working aliquots reduce spoilage, and regular quality checks catch problems early. For projects requiring large-scale runs, splitting bulk shipments into smaller bottles keeps exposed material fresh.
Tales of mislabeling and accidental substitution with o- or p-brominated isomers still crop up, especially in high-throughput environments. Maintaining strong inventory control—using modern barcoded systems—cuts down on mixups. The shared experience in industry and academia has shown that setting up clear SOPs around these valuable intermediates not only prevents wasted time but also reduces accidents and lost productivity.
Modern synthetic chemistry presses beyond old boundaries partly thanks to intermediates like 3-bromophenylacetone. This isn’t a chemical relegated to textbooks; it sits in the middle of pathways to anticonvulsants, new agrochemicals, and custom performance materials. Research now leans into greener, more efficient methods. Photoredox and flow chemistry approaches treat compounds like 3-bromophenylacetone as reliable feedstocks, ready to undergo precise transformations with minimal waste.
Teams looking to reduce environmental impact find opportunities within the molecule’s structure itself. Ongoing advances in catalyst development open up milder and more selective transformations. In meetings with green chemistry advocates, I’ve listened to presentations where teams described major cuts in energy use and waste output—all while building on the same brominated intermediate. The shift isn’t science fiction; it happens where teams thoughtfully pair substrate reactivity with emerging technology.
A compound’s usefulness isn’t just measured in technical reports. Reliable supply chains keep 3-bromophenylacetone firmly available for labs and manufacturing plants alike. Over the past decade, fluctuations in halogen supply have spurred some price hikes, but the demand remains consistent because alternative routes rarely offer the same combination of versatility and predictability.
Experienced buyers often talk about securing multi-year contracts for this intermediate, locking in prices and guaranteeing delivery even during market instability. This stability means R&D departments can map out multi-step syntheses with more confidence, avoiding emergencies that cost both time and money.
3-Bromophenylacetone doesn’t grab headlines, but its indirect influence stretches wide. Some of today’s high-value pharmaceutical agents trace their roots to carefully optimized routes involving this intermediate. The compound’s well-understood chemistry ensures high tolerability for quality by design (QbD) approaches. From my consulting with startups, I’ve seen up-and-coming drug discovery efforts prefer trusted intermediates to maximize their shot at reproducible results and easier tech transfers to manufacturing partners.
In specialty chemicals, such as dyes, UV filters, and polymer modifiers, the compound’s bromine makes new property profiles possible. Performance tweaks often come down to tiny changes—like shifting a substituent here or there. By starting with a compound as adaptable as 3-bromophenylacetone, teams can rapidly spin off new variants for testing, a major factor in staying ahead in competitive fields.
Looking ahead, the role of reliable intermediates keeps growing. Younger chemists now enter a field far more data-driven than even a decade ago. Platforms that track reaction outcomes, monitor supply chains, and flag safety issues rely on chemical inputs that behave predictably. From my years in academic mentorship, I’ve seen new researchers gravitate toward established compounds—like 3-bromophenylacetone—because so much supporting data exists. They see less need to “tough out” obscure reagents with high failure rates or regulatory question marks.
By focusing on well-characterized and accessible chemicals, new generations of chemists free up their creativity for building new science, not just troubleshooting old problems. This culture shift already shows up in grant proposals, investment strategies, and technology adoption.
3-Bromophenylacetone may not dazzle with novelty, but it represents the quiet power of thoughtful design and time-tested functionality. Its robust presence in research and production circles confirms the notion that true innovation often rides on the shoulders of dependable, well-understood starting points. In our fast-changing world, where new molecules hit the drawing board every day, sticking with such reliable intermediates shows that progress sometimes comes from doubling down on what already works—improving, refining, and building better solutions from the inside out.